Novo Nordisk expects Catalent deal to close later this year Reuters via biedexmarkets.com

© Reuters. FILE PHOTO: The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo

COPENHAGEN (Reuters) – Novo Nordisk (NYSE:) expects to close its acquisition of Catalent (NYSE:) later this year, its chief financial officer said during the company’s capital markets day on Thursday, adding that Novo’s gross margin is seen falling in the coming years.

See More News

Bitcoin tops $68K, nearing Silver's $1.38T market cap

XAG/USD stays on sidelines around $28.60 ahead of US Inflation data

Blackhawk Network to buy Tango Card

Tandem appoints Suavek Zajac as CTO

Ispire Technology Reports $5.9M Quarterly Loss, Looks Toward Partnerships To Propel Company Into Profitable Territory - Acreage Holdings (OTC:ACRHF), Ispire Technology (NASDAQ:ISPR)

Ispire Technology Reports $5.9M Quarterly Loss, Looks Toward Partnerships To Propel Company Into Profitable Territory – Acreage Holdings (OTC:ACRHF), Ispire Technology (NASDAQ:ISPR)

top